John Mascarenhas Selected Research

John Mascarenhas Research Topics

Disease

46	Primary Myelofibrosis (Myelosclerosis) 07/2022 - 06/2012
29	Neoplasms (Cancer) 10/2022 - 11/2010
27	Polycythemia Vera 12/2022 - 05/2009
11	Essential Thrombocythemia 12/2022 - 06/2014
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2014
10	Splenomegaly 01/2022 - 06/2012
7	Cytopenia 01/2022 - 01/2013
6	Anemia 01/2022 - 01/2015
6	Thrombosis (Thrombus) 01/2022 - 11/2015
5	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2012
5	Thrombocytosis (Thrombocythemia) 01/2022 - 07/2012
5	Fibrosis (Cirrhosis) 01/2021 - 01/2016
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022 - 09/2012
4	Leukemia 01/2022 - 01/2016
4	Hematologic Neoplasms (Hematological Malignancy) 04/2020 - 06/2012
4	Hemorrhage 01/2020 - 01/2018
3	Infections 06/2022 - 03/2014
3	Disease Progression 05/2022 - 03/2016
3	Blast Crisis (Blast Phase) 01/2022 - 03/2011
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021 - 04/2020
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 09/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2021 - 09/2012
2	COVID-19 12/2020 - 10/2020
2	Bone Marrow Failure Disorders 12/2017 - 03/2014
1	Agammaglobulinemia (Hypogammaglobulinemia) 06/2022
1	Residual Neoplasm 06/2022
1	von Willebrand Diseases (von Willebrand's Disease) 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 03/2021
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Philadelphia Chromosome 12/2020
1	Lymphopenia (Lymphocytopenia) 10/2020
1	Pneumonia (Pneumonitis) 10/2020

Drug/Important Bio-Agent (IBA)

26	ruxolitinibIBA 01/2022 - 06/2012
10	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 03/2016
7	Janus Kinase InhibitorsIBA 07/2022 - 01/2013
7	Phosphotransferases (Kinase)IBA 10/2021 - 01/2015
6	InterferonsIBA 12/2022 - 11/2010
6	CytokinesIBA 01/2022 - 08/2011
5	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2022 - 01/2018
5	Biological ProductsIBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2011
4	Janus Kinase 2IBA 01/2022 - 11/2010
4	fedratinibIBA 01/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2018
3	imetelstatIBA 07/2022 - 10/2021
3	RG7388IBA 01/2022 - 01/2019
3	anagrelide (Agrylin)FDA LinkGeneric 01/2022 - 06/2015
3	Janus KinasesIBA 01/2022 - 01/2013
3	AnticoagulantsIBA 10/2021 - 01/2020
3	CollagenIBA 01/2021 - 01/2016
3	PanobinostatIBA 01/2017 - 07/2012
3	Histone Deacetylase InhibitorsIBA 01/2017 - 07/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2022 - 10/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 03/2016
2	peginterferon alfa-2a (Pegasys)FDA Link 01/2022 - 10/2019
2	Hemoglobins (Hemoglobin)IBA 08/2021 - 01/2018
2	venetoclaxIBA 04/2021 - 11/2020
2	lestaurtinibIBA 01/2019 - 01/2015
2	Janus Kinase 1IBA 01/2018 - 03/2016
2	Reticulin (Reticular Fiber)IBA 09/2017 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2017 - 01/2017
2	Thrombopoietin (c-mpl Ligand)IBA 01/2016 - 01/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 02/2014
2	Pharmaceutical PreparationsIBA 01/2016 - 07/2012
2	Erythropoietin FDA Link 01/2013 - 04/2012
2	ChromatinIBA 08/2011 - 11/2010
1	blinatumomabIBA 06/2022
1	Immunoglobulin G (IgG)IBA 06/2022
1	Immunoglobulins (Immunoglobulin)IBA 06/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2022
1	micaIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Syntex adjuvant formulationIBA 01/2022
1	romidepsin (FK228)FDA Link 01/2022
1	Drug CombinationsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	pembrolizumabIBA 12/2021
1	Decitabine FDA Link 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	GATA1 Transcription FactorIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	fibrin fragment D (D-dimer)IBA 12/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2020
1	Rituximab (Mabthera)FDA Link 10/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020
1	AntibodiesIBA 10/2020
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020

Therapy/Procedure

50	Therapeutics 12/2022 - 06/2010
6	Induction Chemotherapy 01/2022 - 01/2016
4	Drug Therapy (Chemotherapy) 06/2022 - 10/2013
4	Hematopoietic Stem Cell Transplantation 12/2016 - 08/2014
2	Splenectomy 01/2021 - 01/2016
2	Transplantation 12/2016 - 09/2012
1	Colectomy 01/2021
1	Bariatric Surgery 01/2021
1	Erythrocyte Transfusion 12/2020
1	Cannula 10/2020